Literature DB >> 9855437

Safety assessment post-licensure.

E Miller1, P Waight, P Farrington.   

Abstract

The objectives of post-licensure surveillance are to identify rare or novel adverse events, estimate their rate of occurrence and distinguish those that are causally related to vaccination. Evidence of causality is based on biological plausibility supported by laboratory evidence of vaccine involvement and/or a statistically significant excess of events in the post-vaccination period. Passive reporting systems have methodological limitations, particularly for ascertaining reliable adverse event rates and investigating causal relationships. In Canada, an active surveillance system (IMPACT) has been established in sentinel paediatric hospitals where nurses scrutinise all admissions for conditions conforming to a defined set of adverse events. While ascertainment of events resulting in hospital admission should be complete, causality is difficult to assess without information on the incidence of such events outside the post-vaccination risk period. The use of computerised data bases which link clinical events with immunisation records have allowed the risk of events such as convulsions attributable to DTP, MMR and Hib vaccines to be defined. The record linkage method promises to be a useful method for routine surveillance of vaccine safety.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855437

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  6 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Health protection and a new strategy for combating infection in children.

Authors:  E G Davies; M Sharland; A Nicoll
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

3.  No evidence of an association between MMR vaccine and gait disturbance.

Authors:  E Miller; N Andrews; A Grant; J Stowe; B Taylor
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

4.  Using electronic medical records to enhance detection and reporting of vaccine adverse events.

Authors:  Virginia L Hinrichsen; Benjamin Kruskal; Megan A O'Brien; Tracy A Lieu; Richard Platt
Journal:  J Am Med Inform Assoc       Date:  2007-08-21       Impact factor: 4.497

5.  No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome.

Authors:  Brent Taylor; Nick Andrews; Julia Stowe; Laila Hamidi-Manesh; Elizabeth Miller
Journal:  Arch Dis Child       Date:  2007-04-27       Impact factor: 3.791

6.  Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom.

Authors:  N Andrews; E Miller; P Waight; P Farrington; N Crowcroft; J Stowe; B Taylor
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.